Chargement en cours...

Emerging Variants of Castration-Resistant Prostate Cancer

Metastatic castration resistant prostate cancer (CRPC) is associated with substantial clinical, pathologic, and molecular heterogeneity. Most tumors remain driven by androgen receptor (AR) signaling, which has clinical implications for patient selection for AR-directed approaches. However, histologi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Curr Oncol Rep
Auteurs principaux: Vlachostergios, Panagiotis J., Puca, Loredana, Beltran, Himisha
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5479409/
https://ncbi.nlm.nih.gov/pubmed/28361223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0593-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!